XENE
NASDAQ · Biotechnology
Xenon Pharmaceuticals Inc
$56.44
+0.44 (+0.79%)
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Price Target
Analyst Price Target
-64.6% upside
Low Target
$12.55
Average Target
$19.98
High Target
$22.13
Current Price
$56.44
Current
$56.44
$56.44
Target
$19.98
$19.98
$12.55
$19.98 avg
$22.13
Scenario Analysis
Bear Case
$12.55
-77.8%
Low target
Base Case
$19.98
-64.6%
Avg target
Bull Case
$22.13
+-60.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$63.95
-11.7% from high
52-Week Low
$28.19
+100.2% from low
50-Day SMA
$42.54
+32.7% vs SMA
200-Day SMA
$37.78
+49.4% vs SMA
RSI (14)
57.5
Neutral
Target vs 52W High
$19.98
-68.8% vs high
Next Earnings Report
May 12, 2026 · After Market Close
2d
until earnings
EPS Est: $-1.21
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 72% | $257.58 | +27.8% |
| AMGN | Hold | 43 | 49% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 26 | 96% | $143.40 | +41.5% |